Wednesday, March 4, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026
    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026
    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

Humans Evolved with their Microbiomes

Like genes, your gut microbes pass from one generation to the next

Taichi A. Suzuki by Taichi A. Suzuki
September 18, 2022
in Trends
0

When the first humans moved out of Africa, they carried their gut microbes with them. Turns out, these microbes also evolved along with them.

The human gut microbiome is made up of hundreds to thousands of species of bacteria and archaea. Within a given species of microbe, different strains carry different genes that can affect your health and the diseases you’re susceptible to.

There is pronounced variation in the microbial composition and diversity of the gut microbiome between people living in different countries around the world. Although researchers are starting to understand what factors affect microbiome composition, such as diet, there is still limited understanding on why different groups have different strains of the same species of microbes in their guts.

We are researchers who study microbial evolution and microbiomes. Our recently published study found that not only did microbes diversify with their early modern human hosts as they traveled across the globe, they followed human evolution by restricting themselves to life in the gut.

The gut microbiome plays a key role in many areas of your health.

Microbes share evolutionary history with humans

We hypothesized that as humans fanned out across the globe and diversified genetically, so did the microbial species in their guts. In other words, gut microbes and their human hosts “codiversified” and evolved together – just as human beings diversified so that people in Asia look different from people in Europe, so too did their microbiomes.

To assess this, we needed to pair human genome and microbiome data from people around the world. However, data sets that provided both the microbiome data and genome information for individuals were limited when we started this study. Most publicly available data was from North America and Western Europe, and we needed data that was more representative of populations around the world.

So our research team used existing data from Cameroon, South Korea and the United Kingdom, and additionally recruited mothers and their young children in Gabon, Vietnam and Germany. We collected saliva samples from the adults to ascertain their genotype, or genetic characteristics, and fecal samples to sequence the genomes of their gut microbes.

For our analysis, we used data from 839 adults and 386 children. To assess the evolutionary histories of humans and gut microbes, we created phylogenetic trees for each person and as well as for 59 strains of the most commonly shared microbial species.

When we compared the human trees to the microbial trees, we discovered a gradient of how well they matched. Some bacterial trees didn’t match the human trees at all, while some matched very well, indicating that these species codiversified with humans. Some microbial species, in fact, have been along for the evolutionary ride for over hundreds of thousands of years.

Two phylogenetic trees comparing human genetic diversity across geographic regions to the genetic diversity of _Collinsella aerofaciens_
These two phylogenetic trees of human participants (left) and one bacterial species (right) closely match, indicating that they likely diversified together over the course of evolution.
Reprinted with permission from Suzuki et al., Science Volume 377, abm7759 (2022), CC BY-NC-ND

We also found that microbes that evolved in tandem with people have a unique set of genes and traits compared with microbes that had not codiversified with people. Microbes that partnered up with humans have smaller genomes and greater oxygen and temperature sensitivity, mostly unable to tolerate conditions below human body temperature.

In contrast, gut microbes with weaker ties to human evolution have traits and genes characteristic of free-living bacteria in the external environment. This finding suggests that codiversified microbes are very much dependent on the environmental conditions of the human body and must be transmitted quickly from one person to the next, either passed down generationally or between people living in the same communities.

Confirming this mode of transmission, we found that mothers and their children had the same strains of microbes in their guts. Microbes that were not codiversified, in contrast, were more likely to survive well outside of the body and may be transmitted more widely through water and soil.

Gut microbes and personalized medicine

Our discovery that gut microbes evolved right along with their human hosts offers another way to view the human gut microbiome. Gut microbes have passed between people over hundreds to thousands of generations, such that as humans changed, so did their gut microbes. As a result, some gut microbes behave as though they are part of the human genome: They are packages of genes that are passed between generations and shared by related individuals.

Personalized medicine and genetic testing are starting to make treatments more specific and effective for the individual. Knowing which microbes have had long-term partnerships with people may help researchers develop microbiome-based treatments specific to each population. Clinicians are already using locally sourced probiotics derived from the gut microbes of community members to treat malnutrition.

Illustration of gut bacteria on intestinal villi.
Gut bacteria could be used to help treat various diseases and conditions.
Artur Plawgo/iStock via Getty Images Plus

Our findings also help scientists better understand how microbes transition ecologically and evolutionarily from “free-living” in the environment to dependent on the conditions of the human gut. Codiversified microbes have traits and genes reminiscent of bacterial symbionts that live inside insect hosts. These shared features suggest that other animal hosts may also have gut microbes that codiversified with them over evolution.

Paying special attention to the microbes that share human evolutionary history can help improve understanding of the role they play in human well-being.

Taichi A. Suzuki, Postdoctoral Research Associate in Microbiome Science, Max Planck Institute for Biology and Ruth Ley, Director, Department of Microbiome Science, Max Planck Institute for Biology

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Source: The Conversation
ShareTweet
Taichi A. Suzuki

Taichi A. Suzuki

Taichi Suzuki is a postdoctoral researcher at the Max Planck Institute in Germany. He earned his Ph.D. at the University of California Berkeley and is starting as an assistant professor at Arizona State University in 2023.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

In this episode of the Daily Remedy Podcast, Tiffany Ryder discusses her insights on healthcare messaging, the impact of COVID-19 on patient trust, and the importance of transparency in health policy. She emphasizes the need for clear communication in the face of divisiveness and explores the complexities surrounding the estrogen debate. Additionally, Tiffany highlights positive developments in health policy and the necessity of effectively conveying these changes to the public.

Tiffany Ryder is a political commentator and public health policy thought leader who publishes the Substack newsletter Signal and Noise: https://signalandnoise.online/


Chapters

00:00 Introduction to Healthcare Conversations
02:58 Signal and Noise: Understanding Healthcare Communication
05:56 The Storytelling Problem in Healthcare
08:58 Navigating Political Divisiveness in Health Policy
11:55 The Role of Media in Health Policy
15:03 Bias in Health Reporting
17:56 Estrogen and Health Policy: A Case Study
24:00 Positive Developments in Health Policy
27:03 Looking Ahead: Future of Health Policy
31:49 Communicating Health Policy Effectively
The Impact of COVID-19 on Patient Trust
YouTube Video ujzgl7HDlsw
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

by Daily Remedy
March 1, 2026
0

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • When Prognosis Becomes Probabilistic

    When Prognosis Becomes Probabilistic

    0 shares
    Share 0 Tweet 0
  • Gaming Therapy

    0 shares
    Share 0 Tweet 0
  • When the Algorithm Is Right

    0 shares
    Share 0 Tweet 0
  • The Fasting Correction

    0 shares
    Share 0 Tweet 0
  • Healthcare Trends

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy